• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

NewLink Genetics Corp

+ Add to Watchlist


28.472 EUR 2.650 10.26%

As of 13:17:39 ET on 11/21/2014.

Snapshot for NewLink Genetics Corp (4NX)

Open: 26.225 Day's Range: 26.225 - 28.938 Volume: 700
Previous Close: 25.822 52wk Range: 13.672 - 38.680 1-Yr Rtn: +90.50%

Stock Chart for 4NX

No chart data available.
  • 4NX:GR 28.938
  • 1D
  • 1M
  • 1Y
Interactive 4NX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 4NX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -1.6420
Est. PEG Ratio -
Market Cap (M EUR) 796.06
Shares Outstanding (M) 27.96
30 Day Average Volume 3,884
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/11/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 4NX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for 4NX

NewLink Genetics Corporation is a biopharmaceutical company. The Company develops and commercializes biologic and small-molecule immunotherapy products intended to treat a wide range of cancers. NewLink's products are designed to harness components of the patient's immune system to fight cancer either alone or in combination with other treatment regimens.

Charles J Link JrChairman/CEO/Chief Scientific OfcrNicholas N VahanianPresident/Chief Medical Ofcr
John B Henneman III "Jack"Exec VP/CFOBrian WileyVP:Business Development
More Company Profile & Key Executives for 4NX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil